CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Open-market buy CEO and President bought 100,000 shares at $10.13 ($1,013,000)
- 4 Open-market sale Director sold 34,854 shares at $23.37 ($814,538)
- 4 Open-market sale Chief Financial Officer sold 73,647 shares at $26.70 ($1,966,375)
- 4 Grant or award Chief Financial Officer acquired 85,000 shares (grant or award)
- 4 Grant or award CEO and President acquired 985,000 shares (grant or award)
- 4 Open-market buy Director bought 9,000 shares at $10.64 ($95,760)
- 4 Open-market sale Director sold 30,000 shares at $11.10 ($333,000)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
- 4 Grant or award Director acquired 43,732 shares (grant or award)
- 4 Grant or award Director acquired 43,732 shares (grant or award)
- 4 Grant or award Director acquired 43,732 shares (grant or award)
- 4 Grant or award Director acquired 43,732 shares (grant or award)
- 4 Grant or award Director acquired 43,732 shares (grant or award)
- 4 Open-market sale CFO, Secretary and Treasurer sold 84,965 shares at an average $19.10 ($1,622,737)
- 4 Open-market sale CEO and President sold 68,220 shares at an average $18.80 ($1,282,527)
- 4 Grant or award CFO, Secretary and Treasurer acquired 25,000 shares (grant or award)
- 4 Grant or award CEO and President acquired 1,080,770 shares (grant or award)
Page 3 of 18 · 353 filings